Jilin Changlong Pharmaceutical (08049) announced interim results. Profit attributable to shareholders of 123 million yuan increased 19.25% year-on-year

According to the Zhitong Finance App, Jilin Changlong Pharmaceutical (08049) announced its 2026 interim results. The group achieved a turnover of 436 million yuan, a year-on-year decrease of 0.87%; profit attributable to the company's shareholders was 123 million yuan, an increase of 19.25% over the previous year; profit per share was 21.92 points.